High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research

Project description

Tumour bioprinting: the future of drug discovery

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• natural sciences › computer and information sciences › software
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs
• medical and health sciences › clinical medicine › oncology
• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › robotics

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

BICO GROUP AB

Net EU contribution

€ 2 450 327,25

Address

Arvid Wallgrens Backe 20
413 46 Goteborg
Sweden

Region

Södra Sverige › Västsverige › Västra Götalands län

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 1 050 140,25